Would you anticipate that b-om would be used off label for many other types of cancers (other than just head and neck) greatly increasing the potential revenue
I believe they only used head and neck patients in this clinical trial because they have a very high probability of getting Ulcerative OM. That was necessary to make sure that the results wouldn't just occur by chance. I'm pretty sure that it wouldn't be "off label" to use in any type of treatment that would cause Ulcerative OM once its approved.